Cargando…

Prioritizing key synergistic circulating microRNAs for the early diagnosis of biliary tract cancer

Biliary tract cancer (BTC) is a highly aggressive malignant tumor. Serum microRNAs (ser-miRNAs) serve as noninvasive biomarkers to identify high risk individuals, thereby facilitating the design of precision therapies. The study is to prioritize key synergistic ser-miRNAs for the diagnosis of early...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Fei, Gao, Ziyu, Liu, Yueyang, Zhou, Guiqin, Gao, Wei, Deng, Chao, Liu, Yuyu, Zhang, Yihao, Ma, Xiaoyan, Wang, Yongxia, Guan, Lili, Zhang, Yafang, Liu, Baoquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582275/ https://www.ncbi.nlm.nih.gov/pubmed/36276146 http://dx.doi.org/10.3389/fonc.2022.968412

Ejemplares similares

Integrated Tissue and Blood miRNA Expression Profiles Identify Novel Biomarkers for Accurate Non-Invasive Diagnosis of Breast Cancer: Preliminary Results and Future Clinical Implications
por: Su, Fei, et al.
Publicado: (2022)

Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers
por: Letelier, Pablo, et al.
Publicado: (2016)

A Comprehensive Evaluation of Disease Phenotype Networks for Gene Prioritization
por: Li, Jianhua, et al.
Publicado: (2016)

Toripalimab in advanced biliary tract cancer
por: Li, Wei, et al.
Publicado: (2022)

Mendelian randomization study of circulating lipids and biliary tract cancer among East Asians
por: Wang, Jun, et al.
Publicado: (2022)

Targeted Therapy in Biliary Tract Cancers
por: Merla, Amartej, et al.
Publicado: (2015)

Synergistic and Pharmacotherapeutic Effects of Gemcitabine and Cisplatin Combined Administration on Biliary Tract Cancer Cell Lines
por: Sakamoto, Yasunari, et al.
Publicado: (2019)

NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?
por: Kiesslich, Tobias, et al.
Publicado: (2019)

Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer
por: Christensen, Troels D., et al.
Publicado: (2022)

Updates in Biliary Tract Cancers
por: Li, Daneng, et al.
Publicado: (2022)

BILIARY TRACT DISORDERS
Publicado: (1984)

Liquid Biopsy from Bile-Circulating Tumor DNA in Patients with Biliary Tract Cancer
por: Han, Jin-Yi, et al.
Publicado: (2021)

Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers
por: Conci, Simone, et al.
Publicado: (2023)

Preoperative biliary drainage for biliary tract and ampullary carcinomas
por: Nagino, Masato, et al.
Publicado: (2008)

Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer
por: Ito, Zensho, et al.
Publicado: (2022)

Deep graph embedding for prioritizing synergistic anticancer drug combinations
por: Jiang, Peiran, et al.
Publicado: (2020)

A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma
por: Chen, Mingwei, et al.
Publicado: (2017)

Diet and biliary tract cancer risk in Shanghai, China
por: Nelson, Shakira M., et al.
Publicado: (2017)

Vimentin-Positive Circulating Tumor Cells as Diagnostic and Prognostic Biomarkers in Patients with Biliary Tract Cancer
por: Han, Sung Yong, et al.
Publicado: (2021)

Influence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts
por: Ye, Fuqiang, et al.
Publicado: (2016)

Diseases of the liver and biliary tract /
Publicado: (1992)

Viral Infections of the Biliary Tract
por: Gupta, Ekta, et al.
Publicado: (2008)

Streptomycin in Biliary Tract Infection
por: Chaudhuri, R. N., et al.
Publicado: (1950)

Diseases of the Liver and Biliary Tract
por: Johnson, Susan E., et al.
Publicado: (2006)

Immunobiology of the biliary tract system
por: Björkström, Niklas K.
Publicado: (2022)

Combination Therapies for Advanced Biliary Tract Cancer
por: Zeng, Weifeng, et al.
Publicado: (2023)

Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer
por: Sun, Danyang, et al.
Publicado: (2019)

Abnormal Anatomical Variations of Extra-Hepatic Biliary Tract, and Their Relation to Biliary Tract Injuries and Stones Formation
por: Khayat, Meiaad F., et al.
Publicado: (2014)

Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers
por: Li, Yun-cheng, et al.
Publicado: (2022)

A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer
por: Reduzzi, Carolina, et al.
Publicado: (2019)

Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Advanced Biliary Tract Cancer
por: Chen, Chen, et al.
Publicado: (2021)

The synergistic effect of high temperature and ozone on the number of deaths from circulatory system diseases in Shijiazhuang, China
por: Fu, Guiqin, et al.
Publicado: (2023)

Percutaneous transhepatic and endoscopic biliary drainage for malignant biliary tract obstruction: a meta-analysis
por: Leng, Jian-jun, et al.
Publicado: (2014)

Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer
por: Zhao, Qing, et al.
Publicado: (2015)

Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers
por: Zhang, Ruyi, et al.
Publicado: (2021)

Primary Carcinomas of the Liver and Biliary Tract
por: Shanmugaratnam, K.
Publicado: (1956)

Biliary tract neoplasms: diagnosis and staging
por: Gore, Richard M., et al.
Publicado: (2007)

Diagnosis of biliary tract and ampullary carcinomas
por: Tsukada, Kazuhiro, et al.
Publicado: (2008)

Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011)

Imaging of malignancies of the biliary tract- an update
por: Hennedige, Tiffany Priyanthi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qbl7vpnjb4mtkh8s3umtc1add4